HC Wainwright & Co. reiterated coverage on Synlogic with a new price target
$SYBX
Biotechnology: Pharmaceutical Preparations
Health Care
HC Wainwright & Co. reiterated coverage of Synlogic with a rating of Buy and set a new price target of $7.00 from $9.00 previously